MFHA1_XENTR
ID MFHA1_XENTR Reviewed; 997 AA.
AC A4IIK1;
DT 23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT 01-MAY-2007, sequence version 1.
DT 03-AUG-2022, entry version 72.
DE RecName: Full=Malignant fibrous histiocytoma-amplified sequence 1 homolog {ECO:0000305};
GN Name=mfhas1;
OS Xenopus tropicalis (Western clawed frog) (Silurana tropicalis).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Silurana.
OX NCBI_TaxID=8364;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Brain;
RG NIH - Xenopus Gene Collection (XGC) project;
RL Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: Probable GTP-binding protein. Functions in innate immunity
CC and more specifically the inflammatory response as a regulator of the
CC Toll-like receptor TLR2 and TLR4 signaling pathways.
CC {ECO:0000250|UniProtKB:Q9Y4C4}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9Y4C4}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; BC136050; AAI36051.1; -; mRNA.
DR RefSeq; NP_001096407.1; NM_001102937.1.
DR AlphaFoldDB; A4IIK1; -.
DR SMR; A4IIK1; -.
DR STRING; 8364.ENSXETP00000000786; -.
DR PaxDb; A4IIK1; -.
DR GeneID; 100125009; -.
DR KEGG; xtr:100125009; -.
DR CTD; 9258; -.
DR Xenbase; XB-GENE-1003080; mfhas1.
DR eggNOG; KOG0619; Eukaryota.
DR InParanoid; A4IIK1; -.
DR OrthoDB; 1013039at2759; -.
DR Proteomes; UP000008143; Chromosome 1.
DR Proteomes; UP000790000; Unplaced.
DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR GO; GO:0009966; P:regulation of signal transduction; IEA:UniProt.
DR Gene3D; 1.10.10.10; -; 1.
DR Gene3D; 3.40.50.300; -; 1.
DR Gene3D; 3.80.10.10; -; 2.
DR InterPro; IPR032171; COR.
DR InterPro; IPR001611; Leu-rich_rpt.
DR InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR InterPro; IPR032675; LRR_dom_sf.
DR InterPro; IPR027417; P-loop_NTPase.
DR InterPro; IPR020859; ROC_dom.
DR InterPro; IPR036388; WH-like_DNA-bd_sf.
DR Pfam; PF16095; COR; 1.
DR Pfam; PF13855; LRR_8; 2.
DR SMART; SM00369; LRR_TYP; 9.
DR SUPFAM; SSF52540; SSF52540; 1.
DR PROSITE; PS51450; LRR; 13.
DR PROSITE; PS51424; ROC; 1.
PE 2: Evidence at transcript level;
KW Cytoplasm; GTP-binding; Immunity; Inflammatory response; Innate immunity;
KW Leucine-rich repeat; Nucleotide-binding; Reference proteome; Repeat.
FT CHAIN 1..997
FT /note="Malignant fibrous histiocytoma-amplified sequence 1
FT homolog"
FT /id="PRO_0000308611"
FT REPEAT 32..53
FT /note="LRR 1"
FT REPEAT 54..76
FT /note="LRR 2"
FT REPEAT 79..100
FT /note="LRR 3"
FT REPEAT 102..123
FT /note="LRR 4"
FT REPEAT 125..146
FT /note="LRR 5"
FT REPEAT 148..170
FT /note="LRR 6"
FT REPEAT 171..192
FT /note="LRR 7"
FT REPEAT 194..216
FT /note="LRR 8"
FT REPEAT 218..239
FT /note="LRR 9"
FT REPEAT 241..262
FT /note="LRR 10"
FT REPEAT 264..286
FT /note="LRR 11"
FT REPEAT 287..308
FT /note="LRR 12"
FT REPEAT 310..331
FT /note="LRR 13"
FT REPEAT 333..354
FT /note="LRR 14"
FT DOMAIN 393..626
FT /note="Roc"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00758"
SQ SEQUENCE 997 AA; 113096 MW; 397EA4319B9822B6 CRC64;
MAGNDTCNNS CDVKTARLWR DAALRSRKLR SSLRQLTLSC VDKRKLILPA DLGDVEVLNL
GNNSLEEVPD GLQSLSAGNL HVLILRRNKF LNVPTAVYHL GRLTELDISY NRLSCLTEAV
GLLGKLKKLC LSHNQLRTLP RQLGMLVDLE ELDVSFNQIT HLPDTMQGLP SLRTLDLDHN
ELCSFPQQLF HVPALEELDF SGNKMLGSLP EGIRSMQSLK ILWLSSTSLC LLPDSICELV
NLESLMLDNN NLHTLPEGFG ALQKLKMLNV SSNAFQDFPV PLLQLVDLEE LYMSRNRLVV
LPEVISCMTK LVTLWLDNNR IRYLPDSIVE LSFLEELVLQ GNQIAILPDD FGKLSKVNIW
KIKDNPLIQP PYEVCMKGIS YIAAYQKELA HSQPAVKPRL KLVLLGLKDA GKTLLRQCLT
DEQNTSTLVQ GYKGIEITNW TADAERGLAF IVYDLAGDQS YDIIKPFFFS PGALYILVVN
LKSYVCKHFY THVGYFIHLI TSKVPHAVVC IVGTHIDLCN EKELEEKCLD IHHQIAVQEK
RDSETLQTLI QTVDKALSQD FDFRASNPHS AFYGVSDKNL RRKKTHFQYL MNSRLQILSP
VLCVSCLDFS NIKRLREKLL SVAEHREIFP NLHRVLPKSW QMLEELHFKP QELWLTWWDS
ARLGLQAGLT EDRMQSALSF LHESGKLLYF EDNQTLKEYV FHNLTKLIDI LNVFFQRDAS
VLFAKLTSDA TADETKVTQF HHYVEGFLLH GLLPTHIIRS LLKPHIKTHQ DLQLILELLE
KMGLCYCINK PKNKLLNGAT VWYKFPCYVK NEAPHAEAWI NGTNISEPCL AVEQLQIEYS
FPFIFPPGLF ARFSVQINSH IVHRSDSKFQ IFAYRGKVPV VVSFQPARGA LQPGILSIAS
HASLPNIWTA WQAITPLVEE LNALLQEWPS LYYTVHVLCS KCLKRGSPNP HPFPGELLSQ
PRPDGVTELI CPKNGSERLN VSLVYPPTPT MISPCSK